A 1.36-Megabase Deletion in Chromosome 18q21.32 Including GRP in a Patient with Epilepsy, Borderline Intellectual Disability, and Multiple Cerebral Cavernous Malformations


Authors: Larry Baum, Youling Guo, Hongsheng Gui, Pak Chung Sham, Stacey S. Cherny, and Patrick Kwan
Page Range: 135-143
Published in: Journal of Biochemistry and Molecular Biology in the Post Genomic Era, 2#2 (2012)
ISSN: 2156-5732

Table of Contents


From analysis of copy number variations (CNVs) in a genome-wide association study (GWAS) of symptomatic epilepsy, we discovered a 1.36 megabase deletion at chromosome 18q21.32 in a patient with borderline intellectual disability, multiple cerebral cavernous malformations (CMs), and complex partial seizures from age one year. The deletion was confirmed by quantitative polymerase chain reaction. The deleted region included the genes ALPK2, MALT1, ZNF532, GRP, RAX, CPLX4, LMAN1, and CCBE1. GRP (gastrin-releasing peptide, or bombesin) and GRP receptor are expressed in the hippocampus, where GRP depolarizes GABAergic interneurons, thus inhibiting CA1 pyramidal neurons and suppressing seizures. GRP receptor gene disruption has previously been reported in a patient with epilepsy and low intelligence. We speculate that the combined effects of multiple CMs and decreased GRP may have induced epilepsy in this patient. The finding of both genetic and structural abnormalities that could have resulted in epilepsy independently and interactively in this patient illustrates the challenge in classifying epilepsy syndromes.

Keywords: epilepsy, genetics, copy number variant, 18q deletion, cerebral cavernous malformation, cavernoma, GRP, bombesin

Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!